RecruitingACTRN12614000449639

The significance of hyperglycaemia in survivors of critical illness and potential mechanisms underlying development of type 2 diabetes


Sponsor

Dr Adam Deane

Enrollment

600 participants

Start Date

Mar 27, 2014

Study Type

Observational

Conditions

Summary

Conditions of temporary glucose intolerance - such as gestational diabetes - identify people who are at risk from subsequently developing type 2 diabetes. This is important as the prompt diagnosis of glucose intolerance allows earlier treatment and a consequent reduction in complications associated with prolonged and untreated hyperglycaemia, dyslipidaemia and hypertension. The possibility that critical illness-associated hyperglycaemia (CIAH) could be a risk factor for subsequent type 2 diabetes has only been evaluated in one study. This study however has substantial limitations, which severely restrict interpretation of these data. If CIAH is a risk factor for development of type 2 diabetes, and the mechanisms underlying any glucose intolerance elucidated, survivors could be screened for diabetes and prompt appropriate therapy instituted.


Eligibility

Sex: Both males and femalesMin Age: 30 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This study is investigating whether people who had high blood sugar during a critical illness (such as intensive care admission) are at greater risk of developing Type 2 diabetes later in life. Researchers will compare survivors of critical illness with high blood sugar against those who had normal blood sugar, and against healthy volunteers, to understand what happens to blood sugar regulation after critical illness. You may be eligible if: - You are between 30 and 70 years old - You were previously admitted to an intensive care unit (ICU) - You either had high blood sugar (hyperglycaemia) during your ICU stay without pre-existing diabetes, OR you had normal blood sugar throughout your ICU stay - Alternatively, you may qualify as a healthy volunteer matched by age, sex, and BMI You may NOT be eligible if: - You are unable to give informed consent - You are currently pregnant - You have had gestational diabetes previously - You have acute or chronic pancreatitis - You are on medications known to affect blood sugar (e.g. steroids) Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Blood test (HBA1c & Fasting Lipids), Oral Glucose tolerance test , Isotope breath test and height, weight and blood pressure will be measured at 3 months, 1, 2, 3, 6 and 10 years of health and unhealt

Blood test (HBA1c & Fasting Lipids), Oral Glucose tolerance test , Isotope breath test and height, weight and blood pressure will be measured at 3 months, 1, 2, 3, 6 and 10 years of health and unhealthy volunteers.


Locations(1)

The Royal Adelaide Hospital - Adelaide

SA, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12614000449639


Related Trials